4 assets in Tardive Dyskinesia

Therapeutic assets addressing Tardive Dyskinesia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
MT-5199 Tardive Dyskinesia	Neurocrine Biosciences	P4	BBB (75)
Varenicline Tardive Dyskinesia	Corporal Michael J. Crescenz VA Medical Center	P4	B (62)
[14c] lpm3770164 Tardive Dyskinesia	Luye Pharma Group Ltd.	P1	CCC (55)
Dipraglurant Tardive Dyskinesia	Addex Pharma S.A.	P2/3	C (38)